Adverum Biotechnologies
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $-3,600 | $0 | $1,000 | $0 |
Gross Profit | -10,643 | 110 | -956 | |
EBITDA | -61,407 | -26,244 | -17,520 | |
EBIT | -62,217 | -27,134 | -18,476 | |
Net Income | -60,530 | -60,530 | -27,134 | -18,476 |
Net Change In Cash | -3,600 | 0 | 1,000 | 0 |
Free Cash Flow | -28,310 | -28,310 | -21,345 | -19,860 |
Cash | 60,652 | 60,652 | 92,851 | 127,321 |
Basic Shares | 10,069 | 20,848 | 20,876 | 20,852 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $3,600 | $3,600 | $7,500 |
Gross Profit | 1,000 | -2,044 | -6,528 | 2,855 |
EBITDA | -135,506 | -118,347 | -147,934 | -140,895 |
EBIT | -139,159 | -123,991 | -154,462 | -145,540 |
Net Income | -130,927 | -117,165 | -154,536 | -145,540 |
Net Change In Cash | 1,000 | 3,600 | 3,600 | 7,500 |
Cost of Revenue | -26,725 | |||
Free Cash Flow | -92,850 | -91,710 | -119,907 | -122,954 |
Cash | 60,652 | 75,000 | 68,431 | 34,195 |
Basic Shares | 19,782 | 10,082 | 9,925 | 9,803 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.95 |
2024-12-31 | -$1.96 |
2024-09-30 | -$1.30 |
2024-06-30 | -$0.89 |
